Supporting innovation in life sciences: Clinical trials, R&D tax and the evolving policy landscape

The life sciences sector continues to play a vital role in driving innovation, attracting investment and delivering advances in healthcare. However, businesses are operating in an increasingly complex environment, balancing growth ambitions with evolving regulation, funding challenges and changing environment priorities.

Join Freeths, ARC and BDO for an insightful discussion exploring some of the key issues currently affecting life sciences organisations, including clinical trials, R&D tax relief and developments within the wider policy landscape.

Bringing together industry specialists and sector experts, the event will provide practical insights into the opportunities and challenges facing innovative business and the factors influencing strategic decision-making across the sector.

Speakers from the clinical trials and life sciences sectors will be announced soon.

The discussion is expected to cover:

• Clinical trial activity and considerations for life sciences organisations

• The role of R&D tax relief in supporting innovation and growth

• Practical issues businesses should be aware of when assessing qualifying activities

• Current government priorities for the life sciences sector

• Emerging policy developments and their potential impact on businesses

• The opportunities and challenges shaping the future of innovation in the UK

Who should attend?

This event is relevant for life sciences businesses, biotech and pharmaceutical companies, founders and CEOs, CFOs and finance teams, in-house legal teams, and investors and advisers operating within the sector.